Latest lorazepam Stories
CUPERTINO, Calif., May 18, 2015 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it has obtained positive results from a multi-dose Phase 1 clinical trial with an oral
- Expects to be eligible for 180 days of marketing exclusivity - POTTERS BAR, England and PITTSBURGH, May 5, 2015 /PRNewswire/ -- Mylan N.V.
POTTERS BAR, England and HYDERABAD, India, April 23, 2015 /PRNewswire/ -- Mylan N.V.
MELBOURNE, Australia, April 20, 2015 /PRNewswire/ -- Bionomics Limited (ASX: BNO, OTCQX: BNOEF) , a biopharmaceutical company focused on the discovery and
POTTERS BAR, England, April 13, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that its subsidiaries Mylan Inc. and Mylan Pharmaceuticals Inc.
LEXINGTON, Massachusetts, January 26, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the United States Food and Drug Administration (FDA) has granted
SALT LAKE CITY and TORONTO, Nov.
A new infographic from open-ended drug and alcohol treatment program A Forever Recovery is revealing shocking facts about the psychoactive drugs commonly known as Benzos (Benzodiazepines).
SNBL Clinical Pharmacology Center, Inc.
Mylan Free to Immediately Resume Distribution of Its Generic Precedex Product PITTSBURGH, Sept. 8, 2014 /PRNewswire/ -- Mylan Inc.
- The parings of haberdine; also, any kind of fragments.